Previous close | 0.8000 |
Open | 0.8000 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.8000 - 0.8000 |
52-week range | 0.3300 - 2.9000 |
Volume | |
Avg. volume | 51,785 |
Market cap | 13.416M |
Beta (5Y monthly) | 2.10 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.8500 |
Earnings date | 27 June 2024 - 01 July 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
In this article, we will take a detailed look at the Latest Insider Trading Activity: 11 Stocks Executives and Directors are Buying. For a quick overview of such stocks, read our article Latest Insider Trading Activity: 5 Stocks Executives and Directors are Buying. There has been extensive research examining the possible link between stock movements and […]
MINNEAPOLIS, April 08, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it is a Silver Sponsor and will be exhibiting at the International Veterinary Academy of Pain Management (“IVAPM”) Pain Management Forum to be held April 14nd to April 16th 2024 at the JW Marriott Indianapolis, Indiana. PetVivo intends to exhibit its lead product
MINNEAPOLIS, April 03, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it will be exhibiting at the American College of Veterinary Sports Medicine and Rehabilitation (“ACVSMR”) Symposium to be held April 11th to April 13th 2024 at the Arthrex Campus in Naples, Florida. PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoC